Martin Moylan Medtronic says tax advantages stemming from the merger with Ireland-based Covidien have made billions of dollars available for stock buybacks and other uses. The medical device company said it now has access to $9.3 billion that had been held by subsidiaries operating outside the U.S. Medtronic plans to use $5 billion of that […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone